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Lead (Pb) poisoning has numerous effects on the erythropoietic system, but the precise mecha-
nism whereby high dose eposure causes anemia is not entirely dear. We previously reported
that Pb eposure is associated with depressed serum erythropoietin (EPO) inprgnat women
residin in aPb miningtown and in a nonexposed town in Kosovo, Yugoslavia. In aprospective
study, we tested the hypothesis that blood Pb concentration (BPb) may be associated with
depressed EPO in children. BPb, hemoglobin (Hgb), and serumEPOwere measuredatages 4.5,
6.5. and 9.5 years in 211, 178, and 234 children, respectively. At 4.5 years ofage, mean BPbs
were 38.9 and 9.0 p/dl in the exposed and nonexposed towns, respectiveldy BPbs gradually
dedined to 28.2 and6.5 pg/dl, respectively, byage 9.5 years. No differenceswere found in Hgb
at anyage. At age4.5yeas, apositive asociation between BPb andEPO (( m 0.21;p - 0.0001),
controlled for Hgb, was found. The magnitude of this asociaion declined to 0.11 at age 6.5
years (p = 0.0103) and 0.03 at age 9.5 years (p = 0.39). These results were confirmed using
repeated measures analyses. Weconcluded that inPb-exposed children, the maintenance ofnor-
md Hgb requires hyperproduction ofEPO. With advancingage (and coninuing exposure), this
compensatory mechanism appears to be failing, suggesting a gradual loss of renal endocrine
function due to Pb exposure. Key work erythropoietin, hematopoiesis, lead, red cel survival.
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High dose environmental lead (Pb) exposure
induces anemia (1-3), the mechanism of
which is notentirely clear. Elevated bloodlead
concentrations (BPbs) are associated with
impaired heme synthesis (46), but even in
severe Pb intoxication, elevated BPbs alone
cannotaccountforthedecrement inhemoglo-
bin (Hgb) synthesis (5). Although porphyrins
rise in Pb intoxication, the absolute depression
ofheme synthesis is inconsequential and can-
not explain the fall in Hgb (5,6). Pb is known
tohaveothereffects onerythrocytes, including
inhibition ofpyrimidine-5'-nucleotidase activ-
ity (7), ineffective erythropoiesis (8), and
shortened red cell survival (9,10), but these
also do not completely explain the effects of
Pb on Hgb concentration.
Several studies suggest important sub-
clinical, perhaps preclinical, defects in
hematopoiesis. Grandjean et al. (11)
described delayed blood regeneration capaci-
ty in Pb-workers who had normal Hgb con-
centrations prior to blood donation. That
report led us to hypothesize that Pb may
inhibit the synthesis of erythropoietin
(EPO), a glycoprotein hormone which regu-
lates both steady-state and accelerated ery-
throcyte production. More than 90% of
EPO is produced in the proximal renal
tubule (12,13) where Pb accumulates; the
remainder is produced in the liver. Indeed,
we previously demonstrated that EPO is sig-
nificandy depressed among pregnant women
with moderately elevated BPbs (14).
Hu et al. (15) subsequently described a
highly significant negative association
between tibia (and patella) bone Pb con-
centration and Hgb among 119 nonane-
mic men from the Carpenters' Union; yet
no association between BPb and Hgb was
found. This report suggests that bone Pb
may be a more important marker ofongo-
ing Pb toxicity than BPb. The authors sug-
gested that the observed associations may
reflect inhibition ofhematopoiesis through
depression of EPO, with bone Pb serving
as a proxyforkidney Pb (15).
As part of a long-term prospective
study of environmental Pb exposure dur-
ing infancy and childhood (16-18), we
examined the associations between BPb
and EPO at ages 4.5, 6.5, and 9.5 years.
We found that children with elevated BPbs
maintain normal Hgb, but require hyper-
production ofEPO to do so. Our working
hypothesis is that children with moderately
elevated BPbs have shortened red cell sur-
vival, a phenomenon previously described
only in children with Pb encephalopathy
(9) and in Pb workers (10).
Methods
This study was conducted in two towns in
Kosovo, Yugoslavia: Kosovska Mitrovica
(K. Mitrovica), the site of a Pb mine,
smelter, refinery, and battery plant; and
Pristina, a relatively nonexposed town 25
miles to the south. Children were selected
for follow-up from a previous prospective
study of 1,502 pregnant women residing in
these towns. Pregnancy outcomes (19,20)
and childhood developmental outcomes
have been previouslydescribed (16-18).
Subjects. In brief, 706 mother-infant
pairs from the pregnancy study were invited
to participate in a follow-up study involving
repeated visits at 6-month intervals. Of
these, the parents of 541 consented and
brought their children to at least one visit.
Ofthose who consented, 311 (53.5%), 267
(49.4%), and 260 (48.1%) participated in
the visits at ages 4.5, 6.5, and 9.5 years,
respectively. For the present study, whole
blood for BPb and Hgb was available for
272, 201, and 234 children at each ofthese
ages, respectively; sera for EPO analyses
were available for 211, 178, and 234 chil-
dren, respectively.
Laboratory analyses. At mid-pregnancy,
delivery, and at each 6-month follow-up visit,
venous blood samples were taken for the
measurement ofBPb (21), erythrocyte proto-
porphyrin [EP (24], and Hgb. At each visit,
additional sera were obtained and frozen
immediately to create a serum bank, from
which the current study is derived. Whole
blood and serum samples were stored at 40C
and -20°C, respectively, and appropriately
transported to Columbia Universitywhere all
assays wereperformed. The laboratorypartic-
ipates in the BPb and EP quality control pro-
gram of the Centers for Disease Control.
During the study period relevant to this
analysis, agreements with the quality control
values for BPb and EP, measured by intra-
dass correlation coefficients, were both 0.99.
All available sera from the visits at ages
4.5, 6.5, and 9.5 years were analyzed in
duplicate for EPO using a commercially
available enzyme immunoassay (23). In our
laboratory, the limit ofdetection ofthe assay
was 0.6 mIU/ml, and the coefficient ofvari-
ation for duplicate measures was 9.8%,
8.3%, and 7.9%, respectively, at ages 4.5,
6.5, and 9.5 years.
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Statistical analysis. The association
between BPb and EPO was examined using
regression methods. Because the distributions
of EPO and BPb are skewed, logarithmic
transformations were used for these variables.
All analyses were performed using SAS ver-
sion 6.12 (SAS Institute, Cary, NC). First, we
evaluated the association between BPb and
EPO ateach age usinglinearregression analy-
sis, controllingforconcurrentHgbconcentra-
tion. Concurrent Hgb was always controlled
because it is the most important predictor of
EPO (13). Second, we combined data from
all ages and used repeated measures analysis
(described below) to determine whether the
associations between BPb and EPO, control-
lingforHgb, changedovertime.
The repeated measures analysis was
based on 614 observations from 346 chil-
dren with EPO, BPb, and Hgb measure-
ments available for at least one time point
(i.e., ages 4.5, 6.5, or 9.5 years). The 614
observations induded 157 (45.5%) children
who had measurements made at one time
point (i.e., one age), 110 (31.8%) children
with measurements from two time points,
and 79 (22.8%) children with data from all
three time points of interest. The repeated
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Figure 1. Mean blood lead (A), hemoglobin (B),
and serum erythropoietin (C) at 4.5, 6.5, and 9.5
years of age in Kosovska Mitrovica (K. Mitrovica)
and Pristina, Yugoslavia. Numbers in parentheses
are the number of observations; the error bars
reflectthe standard error.
measures analysis was performed using the
marginal linear model [GEE (24)], which
takes into account the within-subject corre-
lations between these variables; the details
ofthis analysis and its findings are provided
in theAppendix.
For the 15 subjects with missing values
for BPb or Hgb at a specific time point, we
used the following algorithm to substitute
values. IfBPb (or Hgb) measurements were
available for both the 6 months prior to
and the 6 months after the missing values,
we substituted the mean ofthese measure-
ments. If BPb (or Hgb) was available for
only one of these time points, that value
was substituted. Thus, substitutions were
made for 12 ofthese 15 subjects.
Results
During the course of the 5-year period,
mean BPb in each town dedined byapprox-
imately 28% (Fig. 1A). Mean Hgb in each
town remained constant andwithin the nor-
mal range (Fig. 1B). At ages 4.5, 6.5, and
9.5, BPbs ranged from 4.6 to 73.1, 3.1 to
71.7, and 2.3 to 58.1 pg/dl, respectively;
hemoglobin concentrations ranged from 9.5
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Figure 2. Mean serum erythropoietin (EPO) con-
centrations in children from Kosovska Mitrovica
(K. Mitrovica) and Pristina, Yugoslavia stratified
by hemoglobin concentration. At 4.5 (A) and 6.5
years of age (B), children in K. Mitrovica had sig-
nificantly higher serum EPO. By 9.5 years of age
(C), serum EPO concentrations were comparable.
Error bars indicate standard error.
to 14.5, 10.7 to 15.1, and 9.6 to 15.3 g/dl,
respectively; and EPO concentrations
ranged from 2.4 to 40.4, 1.6 to 27.1, and
2.1 to 24.0 mU/ml, respectively. In Pristina,
the mean EPO rose steadily over time from
5.6 to 8.8 mIU/ml (Fig. IC). In K.
Mitrovica, EPO rose between ages 4.6 and
6.5 years (from 7.8 to 9.7 mIU/ml) and
then declined to 8.8 mIU/ml at age 9.5
years. The differences in EPO between
towns were statistically significant at ages
4.5 (p = 0.0017) and 6.5 years (p = 0.02),
withhigherconcentrations in K. Mitrovica.
Because Hgb is a strong determinant of
EPO (13), EPO was examined within Hgb
strata for each age (Fig. 2). Few children
were anemic; there were 9, 1, and 1 children
with Hgb below 11.0 g/dl at ages 4.5, 6.5,
and 9.5 years, respectively. Within each Hgb
stratum, EPO was higher in K. Mitrovica
except at age 9.5 years, when the town differ-
ences diminished.
Associations between BPb and EPO,
adjusted forHgb andspecificto each age, are
shown in Table 1. As expected in each of
these models, Hgb was inversely and signifi-
candy associated with EPO. Statistically sig-
nificant associations between BPb and EPO
were found at ages 4.5 and 6.5 years; howev-
er, the magnitude of the association at age
6.5 was approximatelyhalfthat atage4.5.At
age 9.5 years, the association was not statisti-
cally significant and was approximately an
orderofmagnitudeless than thatatage4.5.
Results of a regression analysis using
repeated measures were similar. At ages 4.5
and 6.5 years, BPb was significantlyandpos-
itively associated with EPO (p<0.0001 andp
= 0.0007, respectively). This association
diminished at 9.5 years ofage. Indeed, the
difference in the association between BPb
and EPO at ages 4.5 and 9.5 years was statis-
tically significant (p = 0.0006), while that
between ages 4.5 and 6.5 was not. To test
whether the association between BPb and
EPO varied by Hgb, we repeated all analyses
indcluding the appropriate interaction terms.
Based on this GEE model and after adjust-
ment for Hgb, a significant interaction
between BPb and age was found, indicating
that the association between EPO and BPb
varied by age (see Appendix). Further analy-
ses foundnointeraction ofHgb andage.
Table 1. Regression coefficients relatng blood lead
concentration to serum erythropoietin concentra-
ton for children 4.5, 6.5, and 9.5 years of age, resid-
ing intwotowns in Kosovo,Yugoslavia
Age(years) (38 SEb p-Value
4.5 0.21 0.043 0.0001
6.5 0.11 0.041 0.0103
9.5 0.029 0.033 0.39
&Regression coefficient controlled forhemoglobin concentration.
bStandard errorforthe regression coefficient
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Discussion
Wepreviouslyreported that Pb exposurewas
associated with depressed serum EPO in
pregnant women (14). Our follow-up
prospective study of their children provided
a unique opportunity to longitudinally
examine subtle hematologic effects of Pb
exposure in a population whose lifetime
exposure has been well characterized. In the
current analyses, we observed that serum
EPO, after adjustment for Hgb, was posi-
tively associated with BPb in children at ages
4.5 and 6.5 years. The findings imply that in
nonanemic Pb-exposed children, increased
erythrocyte production is required to main-
tain normal Hgb concentrations. There is
strong evidence, discussed below, to support
the condusion that this compensatory mech-
anism is a response to Pb-induced shortened
red cell survival. With age, however, the
adjusted regression coefficients between BPb
and EPO (Table 1) declined from 0.21 at
4.5 years (p = 0.0001) to 0.11 at 6.5 years (p
= 0.0103), to 0.03 at age 9.5 years (p =
0.39). It is possible that this gradual decline
in slope was due to the modest decline in
mean BPb as children aged, i.e., that BPbs
fell below a critical threshold for the putative
Pb effect. However, our previous study in
pregnant women (14) found depressed
serum EPO in women whose BPbs were
substantially lower than the children in the
current study. Thus, it appears more likely
that the dedine in slope with age reflects a
gradually decreasing ability to produce EPO.
We also note, however, that the relationship
between BPb and EPO is subtle because the
observed serum EPO concentrations in this
cohort were nearly all within the published
age-related norms (25).
A review byAub et al. in 1925 (1) con-
cluded that although severe plumbism in
man may involve "bone marrow failure,"
anemia was initially due to accelerated
destruction of circulating red cells, a phe-
nomenon first suggested inthe 19th century
(26,27). Supportive mechanistic studies
revealed that patients with plumbism had
redcell membranedefectswhichwere associ-
ated with increased red cell mechanical
fragility and decreased osmotic fragility (1).
In animals, Pb-induced anemiawas found to
be reversed by removal ofthe spleen (28),
which removes abnormal and/or aged red
cells from circulation.
Numerous animal studies indicate that
a two-step sequence ofevents is involved in
Pb-induced anemia. For example, in rabbits
acutely poisoned with Pb, peripheral red
cell destruction was followed by active bone
marrow hyperplasia (29), indicative (in ret-
rospect) of active renal EPO production.
With time, however, rabbit bone marrow
activity declined, suggesting either failure of
erythropoietic stem cells, a decline in renal
EPO production, or both. The same tem-
poral sequence has been described in chil-
dren. Leikin and Eng (9) described short-
ened 51Cr red cell survival in children with
BPbs of 60-238 pg/dl. Among their
patients whose Pb exposure was short in
duration, turnover of 59Fe in plasma was
abnormallyhigh, indicative ofbone marrow
hyperactivity; in those with long-term Pb
exposure iron turnover was depressed, con-
sistentwith marrowhypoactivity.
Our finding that BPb was positively
associated with EPO in children at ages 4.5
and 6.5 years is consistent with the first
pathophysiologic step, i.e., peripheral red
cell destruction, renal EPO production, and
bone marrow hyperactivity. Our earlier
finding that EPO is negatively associated
with BPb in moderately anemic pregnant
women [average age = 26 years (14)] is con-
sistent with the second pathophysiologic
We fittd a reeated masuresmodel using the gneralized esiatin ...equations.(.GEE) metoooy
This odelallos foindpenent efet of age and blo lead concentration h('BPb) at.each age on
erythropoietin (EPO).aech age. In all', 346 observations 'we're,available for this analysis (La., 346
mesres ofEPO). The regrssio oe ae h om
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~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~7 e- 0,
whee
EP'O1 =E;PO concentratio'nforthe in"ch'ild atvisitj
a.. =age.ofthei* child atvisitj
BI'b, BPb ortheit child a iij
Kg1 avrgeo thej'chlsUg atvisit ,,nd3 n
l(.) cidatrvariable takn h valuesofeither0or.
The esuts o th moe aesown below.
Talel Rgressionicoeffictient.estimates,and:stndard errors (SE)
Variables Coeffcient Estiate SE pValu
Age 4.5 (a.,,) ~~1.35W 015 04001.
Age 9.5 (a2) ~~~~1.7453 0.852 <001
BPb.age4.5 (.s 0.2105 0.0421 <0.0001
BPbage 6.5 (~) 0.1331 0.32 0.0007
B.Pb.aei. 9.5 (.) 0.0450 0.0324 0.1645
11g -0.09 0.15 < .01
Diference i
Variable's coefficient. 'Estimate 'SE P-Value
Ag y.s.4.5 (a-a) 0.2967 0.0569 <0.00101.
Age 9.5 vs4.5 (a~a0) 0.3953 0)8 000
BPb aget5vs4.5 $~4~) -0.1W .48 .00
The results.ofthis ansi ar costn wit th ciml regression mnodels
presented inthe main body ofthe paper. EPO ap'pears to increase with increas
ing BPb at ages U. and 15 years, .but.that relationship flattens out at age 9.5
years..Moreover,the regression.coefficient ataegs4.5and9.5years aresignifi-
ca M iferent sugstn st diffrec inthe effctofB.Pb ths gs
step, i.e., bone marrow hypoactivity due to
chronic renal, and possibly marrow, Pb tox-
icity. We speculate that the lack ofassocia-
tion between BPb and EPO at age 9.5 years
of age may represent a transitional period,
possibly leading to insufficient EPO com-
pensatory reserves later in life.
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